Avalo Therapeutics
AVTX
AVTX
12 hedge funds and large institutions have $210K invested in Avalo Therapeutics in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$141K | |
| 2 | +$43.3K | |
| 3 | +$14.2K | |
| 4 |
FIA
FNY Investment Advisers
New York
|
+$4K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$986 |
Top Sellers
| 1 | -$34K | |
| 2 | -$22K | |
| 3 | -$19.8K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$16.1K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$11.1K |